Hydroxyurea 相關新聞

Hydroxyurea 目前有 3 則相關新聞報導，預測適應症 10 個。

本頁整合 Hydroxyurea 的 AI 預測適應症與最新健康新聞，橘色標示的適應症表示近期有相關新聞報導。

藥物資訊

原適應症: 慢性骨髓性白血病、復發／轉移或不可開刀之卵巢癌、併用放射治療之頭頸部鱗狀細胞癌局部控制
證據等級: L2
預測適應症（10 個）:
- female breast carcinoma (100.0%)
- sickle cell-hemoglobin E disease syndrome (99.7%)
- sickle cell-hemoglobin c disease syndrome (99.7%)
- hereditary persistence of fetal hemoglobin-sickle cell disease syndrome (99.7%)
- sickle cell-hemoglobin d disease syndrome (99.7%)
- sickle cell-beta-thalassemia disease syndrome (99.7%)
- cervical adenosarcoma (99.4%)
- colon mucinous adenocarcinoma (99.3%)
- rectum mucinous adenocarcinoma (99.3%)
- gallbladder mucinous adenocarcinoma (99.3%)

相關新聞（3 則）